AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Mehmet Oz is pledging to divest from a broad portfolio of health care stocks if he is confirmed as President Trump’s pick to ...

Non-profit healthcare provider HCA Inc printed the biggest trade of the week as it raised $5.25bn in a six-part offering to repay its borrowing facility. Wells Fargo, Barclays, Bank of America, Citi, ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

Vysis, Inc., a leading genomic disease management ... a new researched-based global biopharmaceutical company – AbbVie. In January 2013, AbbVie was formed. It began trading independently on ...

The Healthcare sector of the economy is front and center on Friday as shares of UnitedHealth drop 7.8%, spurring a widespread market selloff across the broader market a ...